This department, the National Institute on Drug Abuse (NIDA), is offering a pre-application for the NIDA Translational Avant-Garde Award. This grant is designed to support basic and clinical researchers dedicated to translating discoveries into safe and efficacious medications for treating diseases of addiction. NIDA seeks advances for disorders stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. The X02 mechanism facilitates this pre-application, serving as the essential first step for the full Translational Avant-Garde Award. While no awards are made directly from this pre-application, the main associated funding opportunity (RFA-DA-10-013) anticipates committing approximately $2 million annually for five years to fund 2-3 awards.
Opportunity ID: 51323
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-10-095 |
Funding Opportunity Title: | Pre-Application for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (X02) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 26, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 22, 2010 |
Current Closing Date for Applications: | Mar 22, 2010 |
Archive Date: | Apr 22, 2010 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities County governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts City or township governments Native American tribal governments (Federally recognized) State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The purpose of this funding opportunity announcement (FOA) is to encourage pre-applications for The NIDA Translational Avant-Garde Award. The NIDA Translational Avant-Garde Award is designed to support dedicated and talented basic and/or clinical researchers with the vision, drive and expertise necessary to translate research discoveries into medications for the treatment of diseases of addiction. Through this FOA, the National Institute on Drug Abuse (NIDA) is committed to making significant advances in the development of safe and efficacious products for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use or abuse. Mechanism of Support. This announcement will utilize the X02 mechanism for submission and consideration of pre-applications. The X02 pre-application is a first step in applying for a Translational Avant-Garde Award. Funds Available and Anticipated Number of Awards. No awards will be made under this announcement. Through the associated FOA (RFA-DA-10-013), NIDA expects to commit approximately $ 2 million per year for 5 years to fund 2-3 awards. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-10-095.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00016039 | Feb 22, 2010 | Mar 22, 2010 | View |
Package 1
Mandatory forms
51323 RR_SF424_1_2-1.2.pdf
51323 PerformanceSite_1_3-1.3.pdf
51323 RR_OtherProjectInfo_1_2-1.2.pdf
51323 RR_KeyPersonExpanded_1_2-1.2.pdf
51323 PHS398_CoverPageSupplement_1_4-1.4.pdf
51323 PHS398_ResearchPlan_1_3-1.3.pdf
Optional forms
51323 PHS_CoverLetter_1_2-1.2.pdf